170 related articles for article (PubMed ID: 9605271)
1. Comparison of vancomycin and cefuroxime for infection prophylaxis in coronary artery bypass surgery.
Vuorisalo S; Pokela R; Syrjälä H
Infect Control Hosp Epidemiol; 1998 Apr; 19(4):234-9. PubMed ID: 9605271
[TBL] [Abstract][Full Text] [Related]
2. Interrupted time series analysis of vancomycin compared to cefuroxime for surgical prophylaxis in patients undergoing cardiac surgery.
Garey KW; Lai D; Dao-Tran TK; Gentry LO; Hwang LY; Davis BR
Antimicrob Agents Chemother; 2008 Feb; 52(2):446-51. PubMed ID: 18025116
[TBL] [Abstract][Full Text] [Related]
3. Surgical site infections after coronary artery bypass surgery, with special reference to antibiotic prophylaxis and risk factors.
Vuorisalo S
Ann Chir Gynaecol; 1998; 87(1):81-2. PubMed ID: 9598244
[No Abstract] [Full Text] [Related]
4. Is single-dose antibiotic prophylaxis sufficient for coronary artery bypass surgery? An analysis of peri- and postoperative serum cefuroxime and vancomycin levels.
Vuorisalo S; Pokela R; Syrjälä H
J Hosp Infect; 1997 Nov; 37(3):237-47. PubMed ID: 9421775
[TBL] [Abstract][Full Text] [Related]
5. Tolerance of vancomycin for surgical prophylaxis in patients undergoing cardiac surgery and incidence of vancomycin-resistant enterococcus colonization.
Kachroo S; Dao T; Zabaneh F; Reiter M; Larocco MT; Gentry LO; Garey KW
Ann Pharmacother; 2006 Mar; 40(3):381-5. PubMed ID: 16478809
[TBL] [Abstract][Full Text] [Related]
6. Cefuroxime as antibiotic prophylaxis in coronary artery bypass grafting surgery.
Mastoraki S; Michalopoulos A; Kriaras I; Geroulanos S
Interact Cardiovasc Thorac Surg; 2007 Aug; 6(4):442-6. PubMed ID: 17669893
[TBL] [Abstract][Full Text] [Related]
7. Clinical consequences and cost of limiting use of vancomycin for perioperative prophylaxis: example of coronary artery bypass surgery.
Zanetti G; Goldie SJ; Platt R
Emerg Infect Dis; 2001; 7(5):820-7. PubMed ID: 11747694
[TBL] [Abstract][Full Text] [Related]
8. Ceftriaxone versus vancomycin prophylaxis in cardiovascular surgery.
Salminen US; Viljanen TU; Valtonen VV; Ikonen TE; Sahlman AE; Harjula AL
J Antimicrob Chemother; 1999 Aug; 44(2):287-90. PubMed ID: 10473238
[TBL] [Abstract][Full Text] [Related]
9. Perioperative antimicrobial prophylaxis in cardiovascular surgery. A prospective randomized trial comparing two day cefuroxime prophylaxis with four day cefazolin prophylaxis.
Geroulanos S; Oxelbark S; Turina M
J Cardiovasc Surg (Torino); 1986; 27(3):300-6. PubMed ID: 3514630
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant vancomycin for antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery.
Bateman BT; Rassen JA; Schneeweiss S; Bykov K; Franklin JM; Gagne JJ; Polinski JM; Liu J; Kulik A; Fischer MA; Choudhry NK
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):472-8. PubMed ID: 23541855
[TBL] [Abstract][Full Text] [Related]
11. Impact of vancomycin surgical antibiotic prophylaxis on the development of methicillin-sensitive staphylococcus aureus surgical site infections: report from Australian Surveillance Data (VICNISS).
Bull AL; Worth LJ; Richards MJ
Ann Surg; 2012 Dec; 256(6):1089-92. PubMed ID: 22824854
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic prophylaxis in cardiothoracic surgery 1990: results of a third survey.
Woods M; Tillman D
Hosp Pharm; 1992 May; 27(5):404, 406-7. PubMed ID: 10170986
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic prophylaxis in open-heart surgery patients: comparison of cefamandole and cefuroxime.
Peterson CD; Lake KD; Arom KV; Love KR
Drug Intell Clin Pharm; 1987 Sep; 21(9):728-32. PubMed ID: 3498617
[TBL] [Abstract][Full Text] [Related]
14. Adding vancomycin to perioperative prophylaxis decreases deep sternal wound infections in high-risk cardiac surgery patients.
Reineke S; Carrel TP; Eigenmann V; Gahl B; Fuehrer U; Seidl C; Reineke D; Roost E; Bächli M; Marschall J; Englberger L
Eur J Cardiothorac Surg; 2018 Feb; 53(2):428-434. PubMed ID: 29045740
[TBL] [Abstract][Full Text] [Related]
15. Vancomycin versus cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections.
Finkelstein R; Rabino G; Mashiah T; Bar-El Y; Adler Z; Kertzman V; Cohen O; Milo S
J Thorac Cardiovasc Surg; 2002 Feb; 123(2):326-32. PubMed ID: 11828293
[TBL] [Abstract][Full Text] [Related]
16. [A prospective, randomized comparative study between cefazolin and cefuroxime as perioperative antibiotic prevention in cardiovascular surgery].
Geroulanos S; Oxelbark S; Turina M
Schweiz Med Wochenschr; 1984 Mar; 114(9):297-303. PubMed ID: 6369532
[TBL] [Abstract][Full Text] [Related]
17. Ceftriaxone vs cefuroxime for infection prophylaxis in coronary bypass surgery.
Sisto T; Laurikka J; Tarkka MR
Scand J Thorac Cardiovasc Surg; 1994; 28(3-4):143-8. PubMed ID: 7792559
[TBL] [Abstract][Full Text] [Related]
18. Prospective randomized comparison of cefodizime versus cefuroxime for perioperative prophylaxis in patients undergoing coronary artery bypass grafting.
Wenisch C; Bartunek A; Zedtwitz-Liebenstein K; Hiesmayr M; Parschalk B; Pernerstorfer T; Graninger W
Antimicrob Agents Chemother; 1997 Jul; 41(7):1584-8. PubMed ID: 9210690
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery.
Poeran J; Mazumdar M; Rasul R; Meyer J; Sacks HS; Koll BS; Wallach FR; Moskowitz A; Gelijns AC
J Thorac Cardiovasc Surg; 2016 Feb; 151(2):589-97.e2. PubMed ID: 26545971
[TBL] [Abstract][Full Text] [Related]
20. A comparison of teicoplanin and cefuroxime as prophylaxis for orthopaedic implant surgery: a preliminary report.
Wall R; Klenerman L; McCullough C; Fyfe I
J Antimicrob Chemother; 1988 Jan; 21 Suppl A():141-6. PubMed ID: 2965126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
